Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 17
First MDL Vioxx Trial Set for Nov. 28 in Houston
Judge Denies Merck Motions for Mistrial in New Jersey Case
Merck Challenges MDL Plaintiffs' Request for Arcoxia Data
Plaintiffs Urge MDL Judge Not to Dismiss 'Headless' Classes
Texas Panel Assigns Consolidated Vioxx Docket to Harris County Judge
Jurors Precluded from Hearing Evidence of Employee Vioxx Ingestion, Stock Trades
Plaintiffs' Counsel Moves Again in N.J. to Centralize Bextra and Celebrex Claims
FDA Rejects Pfizer's Application to Sell Bextra 'Pro-Drug'
